Associated Papers
Favorable prognostic impact in loss of TP53 and PIK3CA mutations after neoadjuvant chemotherapy in breast cancer.
Jiang YZ et al.
Cancer Research, 2014
24924774 (PubMed )
Supplement: 00085472can140092-sup-tab1-12fig1-5.pdf
Select a paper to view details